APSR2026-924

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-016
P71
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1222936-46904-Abstract poster B.Batmunkh AP08-016_432742.pdf
Format: PDF Only
06. Tuberculosis
1

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Batmunkh Batsan * National Center for Communicable Diseases Tuberculosis clinic emergency department Ulaanbaatar Mongolia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Batmunkh
Batsan
baagi.doctor3@gmail.com
+97691922010
31-40
Mongolia
Original Research
Clinical and Epidemiological Characteristics and Diagnostic Yield of Xpert MTB/RIF Ultra among Patients with Suspected Tuberculosis Based Study
Maximum 25 words
Abstract Content
Assessing the diagnostic contribution of bronchial washing specimens and rapid molecular testing is clinically important in patients with suspected tuberculosis who are smear-negative, sputum-scarce, or unable to expectorate. Method: We conducted a retrospective analytic study using laboratory registry data from 308 suspected tuberculosis cases who underwent bronchial washing in 2025. Variables included age, sex, referring facility, testing purpose, disease form, smear microscopy, Xpert MTB/RIF Ultra result, rifampicin susceptibility, and HIV testing status.
We conducted a retrospective analytic study using laboratory registry data from 308 suspected tuberculosis cases who underwent bronchial washing in 2025. Variables included age, sex, referring facility, testing purpose, disease form, smear microscopy, Xpert MTB/RIF Ultra result, rifampicin susceptibility, and HIV testing status.
Of the 308 cases, 168 (54.5%) were male and 140 (45.5%) were female, with a mean age of 49.6 ± 17.8 years. New diagnostic cases accounted for 268 (87.0%) and pulmonary disease for 280 (90.9%). HIV testing status was unknown in 235 (76.3%) cases. Xpert Ultra was performed in 306/308 (99.4%) cases and detected MTB in 77 (25.0%), whereas smear microscopy was positive in only 7 (2.3%) cases. Among Xpert-positive cases, 70/77 (90.9%) were smear-negative, demonstrating substantial incremental diagnostic yield. Among MTB-positive cases, 56 were rifampicin-susceptible, 8 were resistant, and 13 were indeterminate.
Xpert MTB/RIF Ultra markedly improves tuberculosis detection in bronchial washing specimens, particularly among smear-negative suspected cases. Routine implementation of Xpert Ultra for bronchial washing samples, together with stronger HIV/TB data capture, may improve diagnostic accuracy and clinical decision-making.
 
 
 
 
 
No
Yes
https://storage.unitedwebnetwork.com/files/1285/1222936-37089-AbstracttableAP08016_432743.png
JPG or JPEG or PNG format ONLY
bronchial washing, smear-negative tuberculosis, rifampicin resistance
maximum 3 keywords and no abbreviations, separated by commas
 
262